Accelerated Immunotherapy Schedules and Premedication

被引：12

作者：

Calabria, Christopher W. ^{[1
]}

Cox, Linda ^{[1
]}

机构：

[1] ENTAA Care, PA, Glen Burnie, MD 21061 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2011年 / 31卷 / 02期

关键词：

Accelerated immunotherapy; Subcutaneous immunotherapy; Schedule; Premedication; PLACEBO-CONTROLLED IMMUNOTHERAPY; SEASONAL ALLERGIC RHINITIS; GRASS-POLLEN EXTRACT; DOG-DANDER EXTRACTS; RUSH-IMMUNOTHERAPY; DOUBLE-BLIND; SYSTEMIC REACTIONS; VENOM IMMUNOTHERAPY; DERMATOPHAGOIDES-PTERONYSSINUS; STANDARDIZED ALLERGEN;

D O I：

10.1016/j.iac.2011.02.001

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Subcutaneous immunotherapy is divided into a buildup and a maintenance phase. Accelerated immunotherapy has the advantage of a reduced number of office visits. Rush and cluster immunotherapy schedules are the most common accelerated schedules used in the United States. A cluster immunotherapy schedule involves the patient receiving several allergen injections sequentially in a single day of treatment on nonconsecutive days. The maintenance dose is reached in 4 to 8 weeks. In rush immunotherapy protocols, higher doses are administered at intervals of 15 to 60 minutes in a period of 1 to 3 days until the maintenance dose is achieved.

引用

收藏

页码：251 / +

页数：14

相关论文

共 53 条

[1]

ARMENTIAMEDINA A, 1989, ANN ALLERGY, V63, P127

[2] REDUCTION OF SIDE-EFFECTS FROM RUSH-IMMUNOTHERAPY WITH HONEY-BEE VENOM BY PRETREATMENT WITH TERFENADINE [J].

BERCHTOLD, E ;

MAIBACH, R ;

MULLER, U .

CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (01) :59-65

[3]

BERNSTEIN JA, 1994, ANN ALLERGY, V73, P423

[4] IMMUNOTHERAPY WITH A STANDARDIZED DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT .3. SYSTEMIC REACTIONS DURING THE RUSH PROTOCOL IN PATIENTS SUFFERING FROM ASTHMA [J].

BOUSQUET, J ;

HEJJAOUI, A ;

DHIVERT, H ;

CLAUZEL, AM ;

MICHEL, FB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (04) :797-802

[5] DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH MIXED GRASS-POLLEN ALLERGOIDS .3. EFFICACY AND SAFETY OF UNFRACTIONATED AND HIGH-MOLECULAR-WEIGHT PREPARATIONS IN RHINOCONJUNCTIVITIS AND ASTHMA [J].

BOUSQUET, J ;

MAASCH, HJ ;

HEJJAOUI, A ;

SKASSABROCIEK, W ;

WAHL, R ;

DHIVERT, H ;

MICHEL, FB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (04) :546-556

[6] DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH MIXED GRASS-POLLEN ALLERGOIDS .1. RUSH IMMUNOTHERAPY WITH ALLERGOIDS AND STANDARDIZED ORCHARD GRASS-POLLEN EXTRACT [J].

BOUSQUET, J ;

HEJJAOUI, A ;

SKASSABROCIEK, W ;

GUERIN, B ;

MAASCH, HJ ;

DHIVERT, H ;

MICHEL, FB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (04) :591-598

[7] DIFFERENCES IN CLINICAL AND IMMUNOLOGICAL REACTIVITY OF PATIENTS ALLERGIC TO GRASS POLLENS AND TO MULTIPLE-POLLEN SPECIES .2. EFFICACY OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, SPECIFIC IMMUNOTHERAPY WITH STANDARDIZED EXTRACTS [J].

BOUSQUET, J ;

BECKER, WM ;

HEJJAOUI, A ;

CHANAL, I ;

LEBEL, B ;

DHIVERT, H ;

MICHEL, FB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (01) :43-53

[8] COMPARISON BETWEEN RUSH IMMUNOTHERAPY WITH A STANDARDIZED ALLERGEN AND AN ALUM ADJUVED PYRIDINE EXTRACTED MATERIAL IN GRASS-POLLEN ALLERGY [J].

BOUSQUET, J ;

GUERIN, B ;

DOTTE, A ;

DHIVERT, H ;

DJOUKHADAR, F ;

HEWITT, B ;

MICHEL, FB .

CLINICAL ALLERGY, 1985, 15 (02) :179-193

[9]

BOUSQUET J, 1986, ANN ALLERGY, V56, P456

[10] Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial [J].

Brockow, K ;

Kiehn, M ;

Riethmuller, C ;

Vieluf, D ;

Berger, J ;

Ring, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (04) :458-463

← 1 2 3 4 5 6 →